RECTAL ADENOCARCINOMA
Clinical trials for RECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a text message save your life? study tests diet nudges for cancer survivors
Disease control CompletedThis study tested whether sending personalized text messages could help colon and rectal cancer survivors eat more whole grains and less refined grains. Researchers enrolled 46 survivors who were not on active cancer treatment to receive nutrition education and 12 weeks of tailor…
Matched conditions: RECTAL ADENOCARCINOMA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug combo tested for Tough-to-Treat colon cancer
Disease control CompletedThis study tested which of two drug combinations worked better to control advanced colorectal cancer that had a specific genetic feature called HER2 amplification. The trial involved 240 patients whose cancer had spread and could not be removed by surgery. One group received two …
Matched conditions: RECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Does removing the main tumor help patients live longer when cancer has spread?
Disease control CompletedThis study aimed to find out if surgically removing the primary rectal tumor before chemotherapy helps patients with incurable, spread cancer live longer than chemotherapy alone. It involved adults with rectal cancer that had spread to other organs where those secondary tumors co…
Matched conditions: RECTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for rectal cancer: trial tests boosting treatment before surgery
Disease control CompletedThis study tested whether adding one of two new drugs (veliparib or pembrolizumab) to standard chemotherapy and radiation could better shrink rectal tumors before surgery. It involved 363 patients with locally advanced rectal cancer that had not spread to distant organs. The goal…
Matched conditions: RECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC